MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00277-019-03653-7

Медицинская библиотека · Annals of hematology · 2019

Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndrome.

Itonaga Hidehiro, Ishiyama Ken, Aoki Kazunari, Aoki Jun, Ishikawa Takayuki, Uchida Naoyuki, Ohashi Kazuteru, Ueda Yasunori, Fukuda Takahiro, Sakura Toru, Ohno Yuju, Iwato Koji, Okumura Hirokazu, Kondo Tadakazu, Ichinohe Tatsuo, Takanashi Minoko, Atsuta Yoshiko, Miyazaki Yasushi

СтатьяПеревод пока не подготовлен

Аннотация

We conducted a nationwide retrospective study to evaluate the outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in 651 patients aged 60-69 years with de novo myelodysplastic syndrome (MDS). We divided patients into two groups: 152 and 499 patients with an early and advanced disease status, respectively. The 3-year overall survival (OS) rate of patients with an early disease status was 45.9% (95% confidence interval [CI], 37.0 to 54.2%). A multivariate analysis revealed five adverse factors for OS: performance status (PS) 2-4 (hazard ratio [HR] 4.48; P < .001), poor cytogenetic risk group (HR 1.83; P = .041), male recipient (HR 2.58; P = .003), use of HLA-mismatched related grafts (HR 4.75; P = .003), and unrelated cord blood (HR 2.47; P = .023). The 3-year OS rate of patients with an advanced disease status was 37.2% (95% CI 32.4 to 41.9%). Five factors correlated with worse OS: PS 2-4 (HR 1.72; P = .003), poor cytogenetic risk group (HR 1.49; P = .003), use of HLA-mismatched related grafts (HR 1.96; P = .015), unrelated cord blood (HR 2.05; P < .001), and the high number of red blood cell transfusions before transplantation (HR 1.85; P = .018). The present results revealed the more frequent utilization of allo-HSCT for MDS patients aged 60-69 years, which increases the curative potential.

Для цитирования: Itonaga Hidehiro, Ishiyama Ken, Aoki Kazunari, Aoki Jun, Ishikawa Takayuki, Uchida Naoyuki, Ohashi Kazuteru, Ueda Yasunori, Fukuda Takahiro, Sakura Toru, Ohno Yuju, Iwato Koji, Okumura Hirokazu, Kondo Tadakazu, Ichinohe Tatsuo, Takanashi Minoko, Atsuta Yoshiko, Miyazaki Yasushi. Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndrome.. Annals of hematology. 2019. DOI: 10.1007/s00277-019-03653-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.